MET gene copy number heterogeneity in non-small cell lung cancer patients resistant to EGFR-TKIs

被引：0
|
作者：
Bai, Q. [1 ]
Chen, Y. [1 ]
Xiao, X. [2 ]
Chang, H. [1 ]
Xin, B. [2 ]
Jia, L. [1 ]
Li, J. [2 ]
Wang, Z. [1 ]
Yu, C. [1 ]
Xiong, H. [3 ]
Zhou, X. [1 ]
机构：
[1] Fudan Univ, Pathol, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Shanghai Yuanqi Biomed Technol Co Ltd, Shanghai, Peoples R China
[3] Shanghai Rightongene Biotechnol Co Ltd, Shanghai, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
203P
引用
收藏
页码：S150 / S151
页数：2
相关论文
共 50 条
  • [21] Outcomes of EGFR-TKIs for patients with non-small cell lung cancer harboring EGFR mutations with poor performance status
    Hashimoto, K.
    Okuma, Y.
    Hakozaki, T.
    Watanabe, K.
    Hosomi, Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [22] Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small cell lung cancer
    Grob, Tobias J.
    Hoenig, Tobias
    Clauditz, Till S.
    Atanackovic, Djordje
    Koenig, Alexandra M.
    Vashist, Yogesh K.
    Klose, Hans
    Simon, Ronald
    Pantel, Klaus
    Izbicki, Jakob R.
    Bokemeyer, Carsten
    Sauter, Guido
    Wilczak, Waldemar
    LUNG CANCER, 2013, 79 (03) : 221 - 227
  • [23] CLINICOPATHOLOGIC FEATURES OF MET GENE COPY NUMBER GAIN IN NON-SMALL CELL LUNG CANCER
    Jin, Yan
    Seo, An Na
    Sun, Pingli
    Kim, Hyojin
    Chang, Hyun
    Chung, Jin-haeng
    Lee, Jong-suk
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S481 - S481
  • [24] High MET Gene Copy Number Leads to Shorter Survival in Patients with Non-small Cell Lung Cancer
    Go, Heounjeong
    Jeon, Yoon Kyung
    Park, Hyo Jin
    Sung, Sook-Whan
    Seo, Jeong-Wook
    Chung, Doo Hyun
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (03) : 305 - 313
  • [25] Role of long noncoding RNA LINC00461 in EGFR-TKIs resistant non-small cell lung cancer
    Lee, Ji Yun
    Thi-Thu-Trang Luu
    Bach, Duc-Hiep
    Hu, Ruoci
    Kim, Donghwa
    Lee, Sang Kook
    CANCER RESEARCH, 2019, 79 (13)
  • [26] Treatment with EGFR-TKIs in Non Small Cell Lung Cancer Patients. The Impact of EGFR Mutations
    Garcia Manrique, Teresa
    Carrillo De Albornoz, Rosario
    Milena Vargas, Ana
    Alamo De la Gala, M. Carmen
    Grueso Lopez, Ana Maria
    Barros Perez, M. Mar
    Vicente Baz, David
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S408 - S408
  • [27] PROTEOMIC SIGNATURE TO IMPROVE OUTCOME IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS TREATED WITH EGFR-TKIS
    Lazzari, Chiara
    Gregorc, Vanesa
    Spreafico, Anna
    Vigano, Mariagrazia
    Milan, Enrico
    Bachi, Angela
    D'Amato, Alfonsina
    Sorlini, Cristina
    Roca, Elisa
    Villa, Eugenio
    ANNALS OF ONCOLOGY, 2009, 20
  • [28] Chemotherapy plus EGFR-TKIs versus EGFR-TKIs Alone in Non-small Cell Lung Cancer with EGFR-Activating Mutations: A Meta-analysis
    Han, G.
    Peng, M.
    Weng, Y.
    Zou, J.
    Song, Q.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E458 - E458
  • [29] Relative Abundance of EGFR Mutations Predict Tumor Metastasis and EGFR-TKIs Prognosis in Patients with Non-Small Cell Lung Cancer
    Wang, Qiming
    Wang, Hongyan
    Tang, Hong
    Wu, Yufeng
    He, Zhen
    Wang, Lili
    Zhang, Zhe
    Zhao, Dongdong
    Yang, Li
    Wei, Bing
    Ma, Jie
    Guo, Yongjun
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S496 - S496
  • [30] Proteins associated with EGFR-TKIs resistance in patients with non-small cell lung cancer revealed by mass spectrometry
    Yang, Shaoyu
    Chen, Xueqin
    Pan, Yuelong
    Yu, Jiekai
    Li, Xin
    Ma, Shenglin
    MOLECULAR MEDICINE REPORTS, 2016, 14 (05) : 4823 - 4829
12345